Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence

Belot, 2008, Cancer incidence and mortality in France over the period 1980–2005, Rev Epidemiol Sante Publique, 56, 159, 10.1016/j.respe.2008.03.117 Gligorov, 2009, Recommandations pour la Pratique Clinique: Nice–Saint-Paul-de-Vence 2009. «cancers du sein», Oncologie, 11, 495, 10.1007/s10269-009-1822-x Bellon, 2005, Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial, J Clin Oncol, 23, 1934, 10.1200/JCO.2005.04.032 EBCTCG, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7 Whelan, 2010, Long term results of hypofractionated radiation therapy for breast cancer, N Engl J Med, 362, 513, 10.1056/NEJMoa0906260 Yarnold, 2005, Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial, Radiother Oncol, 75, 9, 10.1016/j.radonc.2005.01.005 START Trialists’ Group, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet, 371, 1098, 10.1016/S0140-6736(08)60348-7 Romestaing, 1997, Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France, J Clin Oncol, 15, 963, 10.1200/JCO.1997.15.3.963 Romestaing, 2009, Ten-year results of a randomized trial of internal mammary chain irradiation after mastectomy, Int J Radiat Oncol Biol Phys, 75, S1, 10.1016/j.ijrobp.2009.07.029 Bartelink, 2001, Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation, N Engl J Med, 345, 1378, 10.1056/NEJMoa010874 Bartelink, 2007, Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial, J Clin Oncol, 25, 3259, 10.1200/JCO.2007.11.4991 Polgar, 2002, Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I–II breast cancer first results of the randomized Budapest boost trial, Strahlenther Onkol, 178, 615, 10.1007/s00066-002-1053-1 Overgaard, 1997, Post operative radiotherapy in high-risk premenopausal women with breast canecr who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial, N Engl J Med, 337, 949, 10.1056/NEJM199710023371401 Overgaard, 1999, Post operative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized Trial, Lancet, 353, 1641, 10.1016/S0140-6736(98)09201-0 Ragaz, 2005, Locoregional radiation therapy in patients with high risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial, J Natl Cancer Inst, 97, 116, 10.1093/jnci/djh297 Nielsen, 2006, Study of failure pattern among high-risk breast cancer patients with or witout postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danich Breast Cancer Cooperative Group DBCG 82 b and c randomized studies, J Clin Oncol, 24, 2268, 10.1200/JCO.2005.02.8738 Wallgren, 1996, Timing of radiotherapy and chemotherapy following breast-conservative surgery for patients with node-positive breast cancer, Int J Radiat Oncol Biol Phys, 35, 649, 10.1016/0360-3016(96)00186-1 Jagsi, 2005, Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation, Int J Radiat Oncol Biol Phys, 62, 1035, 10.1016/j.ijrobp.2004.12.014 Veronesi, 1983, Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients, Ann Surg, 198, 681, 10.1097/00000658-198312000-00002 Pierce, 2005, Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer, J Clin Oncol, 23, 24, 10.1200/JCO.2005.01.198 Ahn, 2005, Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates, J Clin Oncol, 23, 17, 10.1200/JCO.2005.09.048 Harris, 2005, Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment, J Clin Oncol, 23, 11, 10.1200/JCO.2005.09.056 Azria, 2010, Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial, Lancet Oncol, 11, 258, 10.1016/S1470-2045(10)70013-9 Arcangeli, 2006, A phase III randomized study on the sequence of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer, Int J Radiat Oncol Biol Phys, 64, 161, 10.1016/j.ijrobp.2005.06.040 Rouëssé, 2006, A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results, Int J Radiat Oncol Biol Phys, 64, 1072, 10.1016/j.ijrobp.2005.10.011 Toledano, 2007, Concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer. Final clinical results of the ARCOSEIN phase III randomized trial, J Clin Oncol, 25, 405, 10.1200/JCO.2006.07.8576 Burstein, 2006, Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer, Int J Radiat Oncol Biol Phys, 64, 496, 10.1016/j.ijrobp.2005.07.975 Taghian, 2001, Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel, J Natl Cancer Inst., 93, 1806, 10.1093/jnci/93.23.1806 Joensuu, 2006, Trastuzumab in combination with docetaxel or vinorelbine as adjuvat treatment of breast cancer: the FinHer trial, N Engl J Med, 354, 809, 10.1056/NEJMoa053028 Romond, 2005, Trastuzumab plus adjuvant chemotherapy for operable HER2 positive breast cancer, N Engl J Med, 353, 1673, 10.1056/NEJMoa052122 Piccart-Gebhart, 2005, Trastuzumab after adjuvant chemotherapy for HER2-positive breast cancer, N Engl J Med, 353, 1659, 10.1056/NEJMoa052306 Benk, 1999, Effect of delay in initiating radiotherapy for patients with early stage breast cancer: results of a natural experiment, Int J Radiat Oncol Biol Phys, 45, 305, 10.1016/S0360-3016(99)90325-5 Mackillop, 1996, The effect of delay in treatment on local control by radiotherapy, Int J Radiat Oncol Biol Phys, 34, 243, 10.1016/0360-3016(95)02049-7 Tsoutsou, 2009, Optimal timing for adjuvant radiation therapy in breast cancer. A comprehensive review and perspectives, Crit Rev Oncol Hematol, 71, 102, 10.1016/j.critrevonc.2008.09.002 Buchholz, 2001, Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy, J Clin Oncol, 19, 2240, 10.1200/JCO.2001.19.8.2240 Truong, 2006, Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer, Am J Surg, 191, 749, 10.1016/j.amjsurg.2005.07.028 Sanghani, 2007, Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool, Am J Clin Oncol, 30, 473, 10.1097/COC.0b013e31805c13d9 Nguyen, 2008, Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy, J Clin Oncol, 26, 2373, 10.1200/JCO.2007.14.4287 Kyndi, 2008, Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group, J Clin Oncol, 26, 1419, 10.1200/JCO.2007.14.5565 Haffty, 2006, Loco-regional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer, J Clin Oncol, 24, 5652, 10.1200/JCO.2006.06.5664 Parikh, 2008, Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression, Int J Radiat Oncol Biol Phys, 70, 35, 10.1016/j.ijrobp.2007.05.066 Belkacémi, 2008, The use of breast cancer subtype classification to predict local and distant recurrence. A review, Cancer Radiother, 12, 577, 10.1016/j.canrad.2008.08.272 Cutuli, 2009, Breast conserving treatment (BCT) for stage I–II breast cancer in elderly women: analysis of 927 cases, Crit Rev Oncol Hematol, 71, 79, 10.1016/j.critrevonc.2008.09.011 Kirova, 2010, Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patients, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2009.10.049 Dzhugashvili, 2010, Surgical clips assist in the visualization of the lumpectomy cavity in three-dimensional conformal accelerated partial-breast irradiation, Int J Radiat Oncol Biol Phys, 76, 1320, 10.1016/j.ijrobp.2009.04.089 Ceilley, 2005, Radiotherapy for invasive breast cancer in North America and Europe: results of a survey, Int J Radiat Oncol Biol Phys, 61, 365, 10.1016/j.ijrobp.2004.05.069 Recht, 2001, Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology, J Clin Oncol, 19, 1539, 10.1200/JCO.2001.19.5.1539 Taghian, 2006, J Clin Oncol, 24, 3927, 10.1200/JCO.2006.06.9054 Taghian, 2004, Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based, Int J Radiat Oncol Biol Phys, 60, 706, 10.1016/j.ijrobp.2004.04.027 Huang, 2008, Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy, Breast Cancer Res Treat, 107, 379, 10.1007/s10549-007-9561-4 Wazer, 1992, Factors influencing cosmetic outcome and complication risk after conserving surgery and radiotherapy for early-stage breast carcinoma, J Clin Oncol, 10, 356, 10.1200/JCO.1992.10.3.356 Taylor, 1995, Factors influencing cosmetic results after conservation therapy for breast cancer, Int J Radiat Oncol Biol Phys, 31, 753, 10.1016/0360-3016(94)00480-3 Fowble, 1996, The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer, Int J Radiat Oncol Biol Phys, 35, 669, 10.1016/0360-3016(96)00185-X Azria, 2004, Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients, Br J Cancer, 91, 1251, 10.1038/sj.bjc.6602146 Bentzen, 1996, Radiotherapy-related lung fibrosis enhanced by tamoxifen, J Natl Cancer Inst, 88, 918, 10.1093/jnci/88.13.918 Koc, 2002, Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients, Radiother Oncol, 64, 171, 10.1016/S0167-8140(02)00136-6 Kesisis, 2009, Update on the use of aromatase inhibitors in early-stage breast cancer, Breast Cancer Res, 11, 211, 10.1186/bcr2410 Recht, 1993, Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome, J Clin Oncol, 11, 191, 10.1200/JCO.1993.11.1.191 Huang, 2003, Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review, J Clin Oncol, 21, 555, 10.1200/JCO.2003.04.171 Recht, 1996, The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer, N Engl J Med, 334, 1356, 10.1056/NEJM199605233342102 Coates, 1998, International Breast Cancer Study Group trials. Recent results, Cancer Res, 152, 429 Belkacemi, 2008, Adjuvant trastuzumab and radiation therapy in patients with HER2 breast cancer: a French multicenter prospective study, Ann Oncol, 19, 1110, 10.1093/annonc/mdn029 Halyard, 2009, Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831, J Clin Oncol, 27, 2638, 10.1200/JCO.2008.17.9549 Kirova, 2009, Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy, Cancer Radiother, 13, 276, 10.1016/j.canrad.2009.02.008 Shaffer, 2009, Acute cardiotoxicity with concurrent trastuzumaband radiotherapy including internal mammary chain nodes: a retrospective single-institution study, Radiother Oncol, 90, 122, 10.1016/j.radonc.2008.09.003 Belkacemi, 2009, Concurrent trastuzumab—Internal mammary irradiation for HER2 positive breast cancer: “It hurts to be on the cutting edge”, Radiother Oncol Bellon, 2005, Concurrent trastuzumab and radiation therapy (RT) in the adjuvant treatment of breast cancer, Proc. Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2005.07.097 Harcourt, 2003, The psychological effect of mastectomy with or without breast reconstruction: a prospective, multicenter study, Plast Reconstr Surg, 111, 1060, 10.1097/01.PRS.0000046249.33122.76 Cordeiro, 2004, Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients, Plast Reconstr Surg, 113, 877, 10.1097/01.PRS.0000105689.84930.E5 Jhaveri, 2008, Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction, Int J Radiat Oncol Biol Phys, 72, 859, 10.1016/j.ijrobp.2008.01.055 Mehta, 2004, Postmastectomy radiation therapy after TRAM flap breast reconstruction, Breast J, 10, 118, 10.1111/j.1075-122X.2004.21286.x Hebert-Croteau, 2004, A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer, Breast Cancer Res Treat, 88, 187, 10.1007/s10549-004-0594-7 Hershman, 2006, Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival, Int J Radiat Oncol Biol Phys, 65, 1353, 10.1016/j.ijrobp.2006.03.048 Mikeljevic, 2004, Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery, Br J Cancer, 90, 1343, 10.1038/sj.bjc.6601693 Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: Report from the Collaborative Update ref by : AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties. AROME. Crit Rev Oncol Hematol. 2010 Apr 15. [Epub ahead of print].